Amyris Biotechnologies creates renewable products, focusing on fuels and chemicals. The company is developing renewable fuels that reduce lifecycle (GHG) emissions 80%. The fuel source is special in that it is compatible with current gasoline engines, and can be distributed with existing petroleum infrastructure.

Amyris is also developing semi-synthetic artemisinin, a key ingredient in first-line malaria treatments, in hopes of creating a complementary source of non-seasonal, high-quality, affordable artemisinin. This source would supplement the current botanical supply, offering millions of people infected with malaria the chance to gain consistent and reliable access to lower-cost, life-saving Artemisinin-based Combination Therapies (ACTs). Amyris produces environmentally friendly chemicals for a variety of consumer products and industrial applications currently dependent on petrochemical components.

Emeryville, US
Size (employees)
418 (est)-3%
Amyris was founded in 2003 and is headquartered in Emeryville, US

Amyris Office Locations

Amyris has an office in Emeryville
Emeryville, US (HQ)
100 5885 Hollis St

Amyris Data and Metrics

Amyris Financial Metrics

Amyris's revenue was reported to be $34.2 m in FY, 2015 which is a 21% decrease from the previous period.

Revenue (FY, 2015)

34.2 m

Revenue growth (FY, 2014 - FY, 2015), %


Gross profit (FY, 2015)

(3.2 m)

Gross profit margin (FY, 2015), %


Net income (FY, 2015)

(218.1 m)

EBIT (FY, 2015)

(148.5 m)

Market capitalization (27-Jun-2017)

63.8 m

Closing share price (27-Jun-2017)


Cash (31-Dec-2015)

12 m
Amyris's current market capitalization is $63.8 m.
USDFY, 2013FY, 2014FY, 2015


41.1 m43.3 m34.2 m

Revenue growth, %


Cost of goods sold

38.3 m33.2 m37.4 m

Gross profit

2.9 m10.1 m(3.2 m)

Gross profit Margin, %


Operating expense total

122.5 m109.9 m145.3 m


(119.6 m)(99.8 m)(148.5 m)

EBIT margin, %


Interest expense

9.1 m28.9 m78.9 m

Interest income

162 k387 k264 k

Pre tax profit

(235.8 m)

Net Income

(234.9 m)2.2 m(218.1 m)
USDFY, 2013FY, 2014FY, 2015


6.9 m42 m12 m


9.5 m6.5 m5.9 m

Current Assets

36.9 m73.6 m35.7 m


140.6 m119 m59.8 m

Total Assets

198.9 m216.2 m110.2 m

Accounts Payable

6.5 m3.5 m7.9 m

Current Liabilities

37.3 m40 m76.8 m

Additional Paid-in Capital

706.3 m724.7 m926.2 m

Retained Earnings

(821.4 m)(819.2 m)(1 b)

Total Equity

(135.8 m)(125.1 m)(158.5 m)

Financial Leverage

-1.5 x-1.7 x-0.7 x
USDFY, 2013FY, 2014FY, 2015

Net Income

(234.9 m)2.2 m(218.1 m)

Depreciation and Amortization

16.6 m15 m12.9 m

Accounts Receivable

(4.4 m)(1.2 m)4.9 m

Accounts Payable

(2.6 m)(3.2 m)4.4 m

Cash From Operating Activities

(105.9 m)(84.7 m)(85.1 m)

Cash From Investing Activities

(10.3 m)(9.8 m)(5.1 m)

Cash From Financing Activities

91.2 m130.9 m61.4 m

Interest Paid

3 m6.9 m9.4 m
Y, 2015

Financial Leverage

-0.7 x

Amyris Market Value History

Amyris Online and Social Media Presence

Amyris Company Life and Culture

You may also be interested in